Alcon Puts Money Where Mouth Is With Glaucoma Device Buy

Barely a month after cutting its pharma portfolio and vowing to up investment in its surgical eye-care business, Novartis AG's Alcon has signed a deal that will bring a new micro-stent technology into its glaucoma portfolio.